CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 666 enrolled
Drug / intervention
Culturally Targeted SARS-CoV-2 Communication +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04957082
NCT04957082N/ACompleted
CompareCT.gov

Culturally-targeted Communication to Promote SARS-CoV-2 Antibody Testing in Saliva: Enabling Evaluation of Inflammatory Pathways in COVID-19 Racial Disparities

Michigan State University·interventional·Posted Jul 12, 2021·Updated Jun 28, 2024

In Brief

A clinical study evaluating Culturally Targeted SARS-CoV-2 Communication and General SARS-CoV-2 Communication for SARS-CoV2 Infection. Completed, enrolled 666 participants across 1 site.

Detailed Summary

This disparities-focused study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing among African Americans residing in Flint, Michigan. This iteration will consider individuals recruited from the Flint Registry and assess willingness to participate in a drive-up saliva sample collection taking place at a central location in Flint, Michigan.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSARS-CoV2 Infection
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), Johns Hopkins University

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 12, 2021
Enrollment StartAug 4, 2021
Primary CompletionDec 19, 2022
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 5.0 years ago

Interventions

Culturally Targeted SARS-CoV-2 Communicationbehavioral

SARS-CoV-2 video tutorial includes a one minute video based messaging adjunct meant to enact a culturally targeted framing of health information presented to African Americans.

General SARS-CoV-2 Communicationbehavioral

SARS-CoV-2 video tutorial is for general consumption and does not include culturally targeted information